Journal
/
/
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
JoVE Journal
Medicina
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Medicina
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
DOI:

08:44 min

September 01, 2016

, ,

Capítulos

  • 00:05Título
  • 00:48In Vivo Stroke Induction
  • 03:06Neurological Deficit Scoring (NDS) and Filament Removal
  • 04:14Intravenous Catheter Jugular Vein Installation for Continuous 48 Hr Treatment
  • 06:28Results: Representative Effects of Continuous I.V. or I.P. Conivaptan Treatment on Stroke-evoked Brain Edema
  • 07:18Conclusion

Summary

Tadução automática

Our studies have revealed that the beneficial effects of conivaptan are dependent on the method of delivery after experimental stroke in mice. We have developed a research protocol for delivery of the receptor blocker via IV catheter on stroke-evoked brain edema formation in mice.

Vídeos Relacionados

Read Article